Ponce GY, Ponce GA

Language: Spanish
References: 23
Page: 287-293
PDF size: 836.64 Kb.

ABSTRACT

The renin-angiotensin system is more complex than was known until recently, since its action is not only limited to the plasma. Its presence has been shown in tissues such as the heart, brain, kidney, pancreas, reproductive system, lymphatic system and adipose tissue, with specific active actions in all of them, and at the same time it is present at the intracellular level of different cell types such as cardiomyocytes and fibroblasts. It is an endocrine, paracrine and autocrine system which is capable of acting at different levels in an independent or related form, taking part not only in the control of blood pressure and homeostasis of water and sodium as initially attributed, but it is also involved in the proper functioning of numerous organs and in the pathophysiological mechanism of structural and functional alterations,mainly cardiovascular and renal, which go far beyond hypertension.

REFERENCES

1. Fyhrquist F, Saijonmaa O. Renin-angiotensin sys-tem revisited. J Intern Med. 2008; 264(3):224-36.

2. Lago F, Lekuona I, González JR. El sistema reni-na-angiotensina intracelular. Papel de la inhibición directa de la renina. Rev Esp Cardiol. 2011;11(Supl D):13-7.

3. Coca A, Díez J. Inhibición directa de la renina: de la fisiología a la farmacología y las implicaciones clí-nicas. Introducción. Rev Esp Cardiol. 2011;11(Supl D):1-2.

4. Morales-Olivas FJ, Estañ L. La actividad de la reni-na plasmática. Papel de la inhibición directa de la renina. Rev Esp Cardiol. 2011;11(Supl D):3-7.

5. Tamargo J, Gómez R, Amorós I, Barana A, Caballe-ro R, Delpón E, et al. Fisiopatología de la prorenina y la renina. Cincuenta años en busca de los inhibi-dores directos de la renina. Sus ventajas y sus limi-taciones. Rev Esp Cardiol. 2009;9(Supl A):24-40.

6. Paul M, Poyan Mehr A, Kreutz R. Physiology of lo-cal renin-angiotensin systems. Physiol Rev. 2006; 86(3):747-803.

7. Bader M, Ganten D. Update on tissue renin-angio-tensin systems. J Mol Med (Berl). 2008;86(6):615-21.

8. Burrell LM, Risvanis J, Kubota E, Dean RG, MacDo-nald PS, Lu S, et al. Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J. 2005;26(4):369-75.

9. Keidar S, Kaplan M, Gamliel A. ACE2 of the heart: from angiotensin I to angiotensin (1-7). Cardiovasc Res. 2007;73(3):463-9.

10. Thone C, Steckelings UM, Unger T. Angiotensin receptor blockers and cerebral protection in stroke. J Hypertens Suppl. 2006;24(1):S115-21.

11. Achard V, Boullu S, Desbriere R, Nguyen G, Grino M. Renin receptor expression in human adipose tissue. Am J Physiol Regul Integr Comp Physiol. 2007;292(1):R274-82.

12. Kondoh G, Tojo H, Nakatani Y, Komazawa N, Mura-ta C, Yamagata K, et al. Angiotensin-converting en-zyme is a GPI-anchored protein releasing factor crucial for fertilization. Nat Med. 2005;11(2):160-6.

13. Takai S, Jin D, Muramatsu M, Miyazaki M. Chy-mase as a novel target for the prevention of vascu-lar diseases. Trends Pharmacol Sci. 2004;25(10): 518-22.

14. Zini S, Fournie MC, Chauvel E, Roques BP, Corvol P, Llorens-Cortes C. Identification of metabolic pathways of brain angiotensin II and III using spe-cific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci USA. 1996;93(21):11968-73.

15. Chai SY, Fernando R, Peck G, Ye SY, Mendelsohn FA, Jenkins TA, et al. The angiotensin IV. AT4 re- ceptor. Cell Mol Life Sci. 2004;61(21):2728-37.

16. Ruiz M, Esteban V, Egido J. The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases. Trends Cardiovasc Med. 2007;17(1):19-25.

17. Ferrario CM. Angiotensin-converting enzyme 2 and angiotensin 1-7: an evolving story in cardiovascular regulation. Hypertension. 2006;47(3):515-21.

18. Santos RA, Ferreira AJ. Angiotensin (1-7) and the renin-angiotensin system. Curr Opin Nephrol Hyper-tens. 2007;16(2):122-8.

19. Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system: a new paradigm. Trends Endocrinol Metab. 2007;18(5):208-14.

20. Schefe JH, Menk M, Reinemund J, Effertz K, Hobbs RM, Pandolfi PP, et al. A novel signal transduction cascade involving physical interaction of the renin/ prorenin receptor with the transcription factor pro-myelocytic zinc finger protein. Circ Res. 2006; 99(12):1355-66.

21. Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system in the heart. Curr Hyper-tens Rep. 2009;11(2):104-10.

22. Singh VP, Baker KM, Kumar R: Activation of the intracellular reninangiotensin system in cardiac fi-broblasts by high glucose: role in extracellular matrix production. Am J Physiol Heart Circ Physiol. 2008;294:H1675-84.

23. Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system: implications in cardiovas-cular remodelling. Curr Opin Nephrol Hypertens. 2008; 17(2):168-73.